{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:40:00Z","timestamp":1792597200553,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Epidemiol Glob Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hemoglobinopathies are among the most prevalent inherited disorders globally, with carrier prevalence varying significantly across regions. In Saudi Arabia, high rates of consanguineous marriages amplify the risk of these disorders.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Aim<\/jats:title>\n                <jats:p>This study aims to assess the burden of hemoglobinopathies by evaluating the prevalence and regional distribution of beta-hemoglobin variants, including rare variants, among couples participating in the national premarital screening program.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Data were collected from the premarital genetic screening program and entered into the SEHA platform, covering the 13 administrative regions of Saudi Arabia. Blood samples underwent various screening tests for infectious and genetic diseases. Hemoglobin electrophoresis samples were analyzed using capillary electrophoresis, High-Performance Liquid Chromatography (HPLC), or a combination of both methods.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>From 2011 to 2018, 1,871,184 individuals were included in the study, with 49.8% male and 50.2% female. The average age was 30.2 years. Hemoglobin S (HbS) was identified in 88,431 individuals (4.7% of the tested population and 78.5% of abnormal screening results), primarily as a sickle cell trait. \u03b2-thalassemia was the second most common disorder, identified in 22,420 individuals (1.2% of the population and 19.9% of hemoglobin disorders). HbC and HbD were each detected in 0.04% of cases, while HbO-Arab was identified in 0.007% and HbG in 0.006%. Hemoglobin E and hemoglobin Lepore were found to be extremely rare.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The study demonstrates regional variation in the prevalence of hemoglobin genetic variants in Saudi Arabia. To effectively mitigate this risk, it is imperative to strengthen public education and awareness, particularly focusing on genetic screening and counseling.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s44197-024-00281-x","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T15:01:53Z","timestamp":1722265313000},"page":"1242-1248","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prevalence and Regional Distribution of Beta-Hemoglobin Variants in Saudi Arabia: Insights from the National Premarital Screening Program\u201d"],"prefix":"10.1007","volume":"14","author":[{"given":"Mansour","family":"Aljabry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suha","family":"Sulimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazi","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Aljabri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaker","family":"Alomary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Aljabri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Sallam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman","family":"Alsultan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,29]]},"reference":[{"key":"281_CR1","doi-asserted-by":"crossref","unstructured":"Williams TN, Weatherall DJ. World distribution, population genetics, and health burden of the hemoglobinopathies. Cold Spring Harb Perspect Med. 2012;2(9).","DOI":"10.1101\/cshperspect.a011692"},{"issue":"2","key":"281_CR2","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.hoc.2015.11.004","volume":"30","author":"FB Piel","year":"2016","unstructured":"Piel FB. The present and future global burden of the inherited disorders of hemoglobin. Hematol Oncol Clin North Am. 2016;30(2):327\u201341.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"6","key":"281_CR3","doi-asserted-by":"publisher","first-page":"480","DOI":"10.2471\/BLT.06.036673","volume":"86","author":"B Modell","year":"2008","unstructured":"Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008;86(6):480\u20137.","journal-title":"Bull World Health Organ"},{"key":"281_CR4","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1038\/srep01671","volume":"3","author":"FB Piel","year":"2013","unstructured":"Piel FB, Howes RE, Patil AP, et al. The distribution of haemoglobin C and its prevalence in newborns in Africa. Sci Rep. 2013;3:1671.","journal-title":"Sci Rep"},{"issue":"6861","key":"281_CR5","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/35104556","volume":"414","author":"D Modiano","year":"2001","unstructured":"Modiano D, Luoni G, Sirima BS, et al. Haemoglobin C protects against clinical Plasmodium falciparum malaria. Nature. 2001;414(6861):305\u20138.","journal-title":"Nature"},{"key":"281_CR6","doi-asserted-by":"crossref","unstructured":"Torres Lde S, Okumura JV, Silva DG, Bonini-Domingos CR, Hemoglobin. D-Punjab: origin, distribution and laboratory diagnosis. Rev Bras Hematol Hemoter. 2015;37(2):120\u20136.","DOI":"10.1016\/j.bjhh.2015.02.007"},{"issue":"4","key":"281_CR7","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1136\/jmg.11.4.341","volume":"11","author":"F Vella","year":"1974","unstructured":"Vella F, Lehmann H. Haemoglobin D Punjab (D Los Angeles). J Med Genet. 1974;11(4):341\u20138.","journal-title":"J Med Genet"},{"issue":"5","key":"281_CR8","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1159\/000207414","volume":"63","author":"MA El-Hazmi","year":"1980","unstructured":"El-Hazmi MA, Lehmann H. Human haemoglobins and haemoglobinopathies in Arabia: Hb O Arab in Saudi Arabia. Acta Haematol. 1980;63(5):268\u201373.","journal-title":"Acta Haematol"},{"issue":"1","key":"281_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3109\/03630269409014144","volume":"18","author":"B Chami","year":"1994","unstructured":"Chami B, Blouquit Y, Bardakdjian-Michau J, et al. Hemoglobin variants in North Africa. Hemoglobin. 1994;18(1):39\u201351.","journal-title":"Hemoglobin"},{"key":"281_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1182\/asheducation-2007.1.79","volume":"2007","author":"E Vichinsky","year":"2007","unstructured":"Vichinsky E. Hemoglobin e syndromes. Hematol Am Soc Hematol Educ Program. 2007;2007:79\u201383.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"6","key":"281_CR11","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1097\/GIM.0b013e318065a9e8","volume":"9","author":"NA Alhamdan","year":"2007","unstructured":"Alhamdan NA, Almazrou YY, Alswaidi FM, Choudhry AJ. Premarital screening for thalassemia and sickle cell disease in Saudi Arabia. Genet Med. 2007;9(6):372\u20137.","journal-title":"Genet Med"},{"issue":"1","key":"281_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jegh.2011.06.002","volume":"1","author":"ZA Memish","year":"2011","unstructured":"Memish ZA, Owaidah TM, Saeedi MY. Marked regional variations in the prevalence of sickle cell disease and beta-thalassemia in Saudi Arabia: findings from the premarital screening and genetic counseling program. J Epidemiol Glob Health. 2011;1(1):61\u20138.","journal-title":"J Epidemiol Glob Health"},{"issue":"3","key":"281_CR13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.4103\/0256-4947.81527","volume":"31","author":"ZA Memish","year":"2011","unstructured":"Memish ZA, Saeedi MY. Six-year outcome of the national premarital screening and genetic counseling program for sickle cell disease and beta-thalassemia in Saudi Arabia. Ann Saudi Med. 2011;31(3):229\u201335.","journal-title":"Ann Saudi Med"},{"issue":"10","key":"281_CR14","first-page":"1480","volume":"29","author":"MM Al-Qurashi","year":"2008","unstructured":"Al-Qurashi MM, El-Mouzan MI, Al-Herbish AS, Al-Salloum AA, Al-Omar AA. The prevalence of sickle cell disease in Saudi children and adolescents. A community-based survey. Saudi Med J. 2008;29(10):1480\u20133.","journal-title":"Saudi Med J"},{"issue":"6","key":"281_CR15","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.26719\/1999.5.6.1147","volume":"5","author":"MA El-Hazmi","year":"1999","unstructured":"El-Hazmi MA, Warsy AS. Appraisal of sickle-cell and thalassaemia genes in Saudi Arabia. East Mediterr Health J. 1999;5(6):1147\u201353.","journal-title":"East Mediterr Health J"},{"key":"281_CR16","doi-asserted-by":"crossref","unstructured":"Alsaeed ES, Farhat GN, Assiri AM et al. Distribution of hemoglobinopathy disorders in Saudi Arabia based on data from the premarital screening and genetic counseling program, 2011\u20132015. J Epidemiol Glob Health. 2018;7 Suppl 1.","DOI":"10.1016\/j.jegh.2017.12.001"},{"issue":"2","key":"281_CR17","first-page":"209","volume":"24","author":"ZM Al-Hawsawi","year":"2003","unstructured":"Al-Hawsawi ZM, Islam MS, Shehata NS. Sickle cell hemoglobin C disease in Saudi Arabia. Saudi Med J. 2003;24(2):209\u201312.","journal-title":"Saudi Med J"},{"issue":"4","key":"281_CR18","first-page":"674","volume":"26","author":"TM Owaidah","year":"2005","unstructured":"Owaidah TM, Al-Saleh MM, Al-Hellani AM. Hemoglobin D\/beta-thalassemia and beta-thalassemia major in a Saudi family. Saudi Med J. 2005;26(4):674\u20137.","journal-title":"Saudi Med J"},{"issue":"12","key":"281_CR19","first-page":"1881","volume":"28","author":"MI El-Mouzan","year":"2007","unstructured":"El-Mouzan MI, Al-Salloum AA, Al-Herbish AS, Qurachi MM, Al-Omar AA. Regional variations in the prevalence of consanguinity in Saudi Arabia. Saudi Med J. 2007;28(12):1881\u20134.","journal-title":"Saudi Med J"},{"key":"281_CR20","doi-asserted-by":"crossref","unstructured":"Alsaeed ES, Farhat GN, Assiri AM et al. Distribution of hemoglobinopathy disorders in Saudi Arabia based on data from the premarital screening and genetic counseling program, 2011\u20132015. J Epidemiol Glob Health. 2017;7(Suppl 1).","DOI":"10.1016\/j.jegh.2017.12.001"},{"key":"281_CR21","doi-asserted-by":"crossref","unstructured":"Rao E, Chandraker SK, Singh MM, Kumar R. Global distribution of \u03b2-thalassemia mutations: an update. Gene. 2023;148022.","DOI":"10.1016\/j.gene.2023.148022"},{"issue":"4","key":"281_CR22","first-page":"804","volume":"9","author":"S Al-Arrayed","year":"2003","unstructured":"Al-Arrayed S, et al. Review of the spectrum of hemoglobinopathies in Bahrain. East Mediterr Health J. 2003;9(4):804\u20139.","journal-title":"East Mediterr Health J"},{"issue":"2","key":"281_CR23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3109\/03630269.2011.557460","volume":"35","author":"AA Al-Riyami","year":"2011","unstructured":"Al-Riyami AA, Ebrahim GJ. National genetic blood disorders prevention program in Oman. Hemoglobin. 2011;35(2):157\u201365.","journal-title":"Hemoglobin"},{"issue":"5","key":"281_CR24","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3109\/03630269.2013.810641","volume":"37","author":"S Denic","year":"2013","unstructured":"Denic S. Hemoglobinopathy among the population of UAE: results from the premarital screening program. Hemoglobin. 2013;37(5):444\u201351.","journal-title":"Hemoglobin"},{"issue":"4","key":"281_CR25","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/09723757.2011.11886153","volume":"11","author":"A Bener","year":"2011","unstructured":"Bener A. Genetic and environmental factors associated with cancer incidence among Gulf population. Int J Hum Genet. 2011;11(4):277\u201383.","journal-title":"Int J Hum Genet"},{"issue":"1","key":"281_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000203708","volume":"96","author":"AD Adekile","year":"1996","unstructured":"Adekile AD. Premarital screening for hemoglobinopathies: the Kuwaiti experience. Acta Haematol. 1996;96(1):1\u20136.","journal-title":"Acta Haematol"}],"container-title":["Journal of Epidemiology and Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44197-024-00281-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44197-024-00281-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44197-024-00281-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T21:09:45Z","timestamp":1727730585000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44197-024-00281-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,29]]},"references-count":26,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["281"],"URL":"https:\/\/doi.org\/10.1007\/s44197-024-00281-x","relation":{},"ISSN":["2210-6014"],"issn-type":[{"value":"2210-6014","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,29]]},"assertion":[{"value":"3 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has received the central institutional review board (IRB) approval from ministry of health, Saudi Arabia (IRB log No: 23\u201318 E). The consent to participate has been obtained according the roles and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"All authors consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}